Abstract:Aims: The gut microbiota has been found to be altered in different inflammatory disorders, but its involvement in the regulation of inflammatory cytokines remains unclear. Therefore, this study aimed to investigate the impacts of gut microbiota on circulating inflammatory cytokines and their potential roles in host diseases. Main methods: Two-sample Mendelian randomization (MR) analyses were conducted using summary-level data from genome-wide association studies (GWAS) to identify significant causal associations between 196 gut microbiota and 41 inflammatory cytokines. Meta-analysis was applied to test the robustness of the results. Enrichment analyses of identified cytokines were further utilized to infer the effects of gut microbiota on the host. Key findings: The MR analyses and meta-analyses identified the following significant causal associations: phylum Euryarchaeota on interleukin-2 (IL-2) (βIVW = 0.085, P = 1.5 × 10-2) and interleukin-8 (IL-8) (βIVW = 0.065, P = 4.1 × 10-2), phylum Tenericutes and class Mollicutes on macrophage inflammatory protein 1a (MIP1a) (βIVW = -0.142, P = 7.0 × 10-3), class Bacilli on hepatocyte growth factor (HGF) (βIVW = -0.106, P = 2.5 × 10-2), order Enterobacteriales on monocyte chemoattractant protein-1 (MCP1) (βIVW = 0.182, P = 1.8 × 10-2), and genus Lachnospiraceae NC2004 group on TNF-related apoptosis-inducing ligand (TRAIL) (βIVW = -0.207, P = 6.0 × 10-4). Enrichment analyses suggested that phylum Euryarchaeota and order Enterobacteriales might be risk factors for certain autoimmune diseases and neoplasms, while the phylum Tenericutes may have a protective effect. Significance: This study represents the first evidence confirming the causal effect of specific gut microbial taxa on circulating inflammatory cytokines and sheds light on their potential roles in the development and progression of various host diseases.

Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis

Gut Microbial Metabolites on Host Immune Responses in Health and Disease

The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective

Microbiota Regulation of Inflammatory Bowel Disease and Colorectal Cancer

Role of intestinal microbiota and metabolites on gut homeostasis and human diseases

Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases

The impact of metabolites derived from the gut microbiota on immune regulation and diseases

The role of intestinal microbiota and metabolites in intestinal inflammation

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

The influence of gut microbiota on circulating inflammatory cytokines and host: A Mendelian randomization study with meta-analysis

Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation

Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation

Microbiota and metabolites in rheumatic diseases

Gut Microbiota-Derived Metabolites in the Development of Diseases

[Gut microbiota and immune-related diseases].

The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease

Microbial Metabolites Determine Host Health and the Status of Some Diseases

Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review

Gut Microbiota-Modulated Metabolomic Profiling Shapes the Etiology and Pathogenesis of Autoimmune Diseases